ONTY And CLDX Announce Initiation Of Immunotherapy Clinical Trials; NPSP Initiates Study Of Teduglutide
November 11, 2014 at 03:05 AM EST
ONTY and CLDX announced they have initiated a combined clinical trial of ONT-10 and varlilumab. NPSP announced the company has initiated a global registration study of teduglutide in pediatric patients.
